Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Wysocki

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Expert Opinion on Investigational Drugs|January 16, 2010
Targeted therapy of hepatocellular cancerPiotr Jan Wysocki
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 22, 2013
Reduced plasma ACE2 activity in dialysis patients: another piece in the conundrum of factors involved in hypertension and cardiovascular morbidity?Jan Wysocki, Daniel Batlle
Kidney360|January 2, 2023
ACE2 in the Urine: Where Does It Come From?Jan Wysocki, Daniel Batlle
Clinical Journal of the American Society of Nephrology : CJASN|August 20, 2016
Urinary Angiotensinogen: A Promising Biomarker of AKI Progression in Acute Decompensated Heart Failure: What Does It Mean?Jan Wysocki, Daniel Batlle
Thescientificworldjournal|September 6, 2005
Angiotensin II and renal tubular ion transportPatricia Valles, Jan Wysocki, Daniel Batlle
Hypertension (Dallas, Tex. : 1979)|June 17, 2015
Angiotensins and the heart: is angiotensin-(1-7) cardioprotective?Jan Wysocki, Lisa Wilsbacher, Daniel Batlle
Clinical Science (London, England : 1979)|November 2, 2020
ACE2, the kidney and the emergence of COVID-19 two decades after ACE2 discoveryEnrique Lores, Jan Wysocki, Daniel Batlle
Hypertension (Dallas, Tex. : 1979)|December 3, 2024
ACE2, From the Kidney to SARS-CoV-2: Donald Seldin Award Lecture 2023Daniel Batlle, Luise Hassler, Jan Wysocki
Biomolecules|December 22, 2019
Novel Variants of Angiotensin Converting Enzyme-2 of Shorter Molecular Size to Target the Kidney Renin Angiotensin SystemJan Wysocki, Arndt Schulze, Daniel Batlle
Clinical Science (London, England : 1979)|March 14, 2020
Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?Daniel Batlle, Jan Wysocki, Karla Satchell
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Expert Opinion on Investigational Drugs|January 16, 2010
Targeted therapy of hepatocellular cancerPiotr Jan Wysocki
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 22, 2013
Reduced plasma ACE2 activity in dialysis patients: another piece in the conundrum of factors involved in hypertension and cardiovascular morbidity?Jan Wysocki, Daniel Batlle
Kidney360|January 2, 2023
ACE2 in the Urine: Where Does It Come From?Jan Wysocki, Daniel Batlle
Clinical Journal of the American Society of Nephrology : CJASN|August 20, 2016
Urinary Angiotensinogen: A Promising Biomarker of AKI Progression in Acute Decompensated Heart Failure: What Does It Mean?Jan Wysocki, Daniel Batlle
Thescientificworldjournal|September 6, 2005
Angiotensin II and renal tubular ion transportPatricia Valles, Jan Wysocki, Daniel Batlle
Hypertension (Dallas, Tex. : 1979)|June 17, 2015
Angiotensins and the heart: is angiotensin-(1-7) cardioprotective?Jan Wysocki, Lisa Wilsbacher, Daniel Batlle
Clinical Science (London, England : 1979)|November 2, 2020
ACE2, the kidney and the emergence of COVID-19 two decades after ACE2 discoveryEnrique Lores, Jan Wysocki, Daniel Batlle
Hypertension (Dallas, Tex. : 1979)|December 3, 2024
ACE2, From the Kidney to SARS-CoV-2: Donald Seldin Award Lecture 2023Daniel Batlle, Luise Hassler, Jan Wysocki
Biomolecules|December 22, 2019
Novel Variants of Angiotensin Converting Enzyme-2 of Shorter Molecular Size to Target the Kidney Renin Angiotensin SystemJan Wysocki, Arndt Schulze, Daniel Batlle
Clinical Science (London, England : 1979)|March 14, 2020
Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?Daniel Batlle, Jan Wysocki, Karla Satchell
Pageof 8